Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:09 PM
Ignite Modification Date:
2025-12-24 @ 11:09 PM
NCT ID:
NCT00914069
Eligibility Criteria:
Inclusion Criteria
* Any type of oncology patients undergoing chemotherapy or post-chemotherapy (without a port/cannula), or over 65 years
* Requires peripheral IV as determined by examining physician
* Requires the IV when a study nurse or resident is available
* Able to sign an informed consent
Exclusion Criteria
* Active systemic or cutaneous infection or inflammation;
* Pre-existing immunodeficiency disorder and/or chronic use of systemic steroids;
* Known, significant history of bleeding diathesis, coagulopathy, von Willebrand's disease or current platelet count \< 100,000 cells/mm3, baseline International Normalized Ratio (INR) ≥1.8, or fibrinogen level less than 150 mg/dl (if received a fibrinolytic agent within prior 24 hours);
* Currently involved in any other investigational clinical trials;
* Previous vascular grafts or surgery at the target vessel access site;
* Females who are pregnant, planning to become pregnant within 3 months of the procedure, or lactating;
* Central line available
* Requirement for immediate IV placement (patient's condition would potentially be compromised if there is a time delay in IV placement)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
90 Years
Study:
NCT00914069
Study Brief:
Protocol Section:
NCT00914069